• Publications
  • Influence
Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke.
OBJECTIVE To evaluate the efficacy of a combined treatment for spastic foot using selective injections of botulinum toxin (BTA) into the tibialis posterior muscle followed by ankle taping, and toExpand
  • 125
  • 9
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
Background The approval of 9-δ-tetrahydocannabinol and cannabidiol (THC:CBD) oromucosal spray (Sativex) for the management of treatment-resistant multiple sclerosis (MS) spasticity opened a newExpand
  • 57
  • 5
Brain involvement in myotonic dystrophy: MRI features and their relationship to clinical and cognitive conditions
A prospective, case‐control study was carried out on 25 patients with myotonic dystrophy (MyD) and 25 healthy subjects using brain magnetic resonance imaging (MRI). The frequency and severity ofExpand
  • 70
  • 4
Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb.
OBJECTIVE Although the botulinum toxin A (BTX-A) treatment has proved effective in spasticity management, no information is available with regard to the effects of repeated injections over time. Expand
  • 99
  • 4
A multidimensional assessment of multiple sclerosis: relationships between disability domains
Objective ‐ i) To test the feasibility of a multidimensional assessment based on both task‐related and self‐evaluation questionnaire scores in patients with multiple sclerosis (MS); ii) to correlateExpand
  • 97
  • 3
Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity
Paraoxonase, an enzyme associated with high density lipoproteins (HDL), plays an important role in the anti-oxidant and anti-inflammatory properties exerted by HDL. Increasing evidence supports aExpand
  • 103
  • 2
Disability Changes After Treatment of Upper Limb Spasticity with Botulinum Toxin
We performed an open label single-blind trial with seventeen patients with moderate to severe upper limb spasticity following stroke or traumatic brain injury, treated with an average dose of 165 MUExpand
  • 43
  • 2
Natalizumab Treatment in Multiple Sclerosis Patients: A Multicenter Experience in Clinical Practice in Italy
We evaluated efficacy of natalizumab in relapsing-remitting multiple sclerosis patients in a clinical practice setting. We report data on the first consecutive 343 patients receiving natalizumab inExpand
  • 20
  • 2
Peripheral neuropathy in myotonic dystrophy: electrophysiological and clinical features.
Peripheral neuropathy was investigated in thirty-one patients with myotonic dystrophy (MyD) and sixteen relatives. Using standard electrophysiological criteria, a sensorimotor axonal peripheralExpand
  • 17
  • 2
A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT Study
Background: Specific cognitive rehabilitation in multiple sclerosis (MS) resulted to be effective compared to no treatment. So far the possible role of an aspecific psychological intervention onExpand
  • 20
  • 2